The emergence and evolution of antimicrobial resistance: Impact on a global scale AY Hwang, JG Gums Bioorganic & medicinal chemistry 24 (24), 6440-6445, 2016 | 130 | 2016 |
Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know SE Conway, AY Hwang, CD Ponte, JG Gums Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (2 …, 2017 | 124 | 2017 |
The benefits of physician-pharmacist collaboration. AY Hwang, TH Gums, JG Gums The Journal of family practice 66 (12), E1-E8, 2017 | 101 | 2017 |
Resistant hypertension: mechanisms and treatment AY Hwang, E Dietrich, CJ Pepine, SM Smith Current Hypertension Reports 19, 1-11, 2017 | 66 | 2017 |
Trends in antihypertensive medication use among US patients with resistant hypertension, 2008 to 2014 AY Hwang, C Dave, SM Smith Hypertension 68 (6), 1349-1354, 2016 | 55 | 2016 |
Use of prescription medications that potentially interfere with blood pressure control in new-onset hypertension and treatment-resistant hypertension AY Hwang, CV Dave, SM Smith American journal of hypertension 31 (12), 1324-1331, 2018 | 27 | 2018 |
Patient satisfaction with extended-interval warfarin monitoring NW Carris, AY Hwang, SM Smith, JR Taylor, K Sando, J Powell, ... Journal of thrombosis and thrombolysis 42, 486-493, 2016 | 12 | 2016 |
High-dose once-weekly semaglutide: a new option for obesity management CL Bradley, SM McMillin, AY Hwang, CH Sherrill Annals of Pharmacotherapy 56 (8), 941-950, 2022 | 9 | 2022 |
Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice CL Bradley, SM McMillin, AY Hwang, CH Sherrill Annals of Pharmacotherapy 57 (7), 822-836, 2023 | 8 | 2023 |
US trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016 AY Hwang, SM Smith Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41 (3 …, 2021 | 6 | 2021 |
Partnering with pharmacists to reduce cardiovascular risk in outpatient settings AY Hwang, SM Smith Journal of the American Heart Association 8 (22), e014705, 2019 | 3 | 2019 |
AHA Journals ME Haas, AE Levenson, X Sun, WH Liao, JM Rutkowski, SD de Ferranti, ... Circulation 134 (1), 2016 | 2 | 2016 |
Changes in Metabolic Parameters of Hemoglobin A1c, Weight, and Blood Pressure During and After COVID-19 Stay-at-Home Orders EM Bickenbach, CL Keegan, MC Brockel, OG Mast, A Ghantae, ... The Journal of the American Board of Family Medicine, 2024 | 1 | 2024 |
The pursuit of optimal semaglutide dosing in type 2 diabetes continues CH Sherrill, AY Hwang The Lancet 402 (10403), 668-669, 2023 | 1 | 2023 |
Association between mental health and self-care behavior among older adults with diabetes according to Behavioral Risk Factor Surveillance System 2019 J Zhou, CH Sherrill, AY Hwang, S Lee Primary Care Diabetes 17 (3), 250-254, 2023 | 1 | 2023 |
Racial and ethnic differences in blood pressure before and after the 2016 United States general election AY Hwang, MI Cardel, SM Smith American Journal of Human Biology 34 (10), e23785, 2022 | 1 | 2022 |
racial/ethnic differences in blood pressure around the time of the 2016 United States general election AY Hwang, MI Cardel, SM Smith Circulation 143 (Suppl_1), A063-A063, 2021 | 1 | 2021 |
Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020 CH Sherrill, AY Hwang Annals of Pharmacotherapy, 10600280231178886, 2024 | | 2024 |
Evaluation of the change in glycated hemoglobin for patients in an employee health program formerly managed by a pharmacist-run ambulatory care clinic L Bou-Ghazale, E Oldham, AW Bundeff, AY Hwang American Journal of Health-System Pharmacy 80 (21), 1564-1569, 2023 | | 2023 |
Implementation of pharmacist recommendations in patients with type 2 diabetes enrolled in an employer-sponsored health plan M Hayes, A Lynch, V Yoder, A Hwang, L Alderman, T Adewodu, D Baker Journal of the American Pharmacists Association 63 (4), S73-S77, 2023 | | 2023 |